NCT04863274

Influence of Additional Physician's Consultations and Short Message Service (SMS) Reminders to Patient Compliance

The Program to Assess the Influence of Routing and In-depth Consultation of Patients With Cardiovascular Risk Factors on the Choice of Medicine and Treatment Compliance

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,912 (actual)
• Sponsor: The League of Clinical Research, Russia · Academic / Other
• Sex: All
• Age: 40 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A systematic collection of retrospective and prospective data based on non-interventional patient observation, aimed to assess the risks, course and outcomes of a disease or a group of diseases: * the retrospective part: database of patients with cardiovascular risks; * the prospective part: observation of patients in the real world medical practice.

Detailed description

The research program will have two parts: Stage 1: identification of patients with moderate, high and very high cardiovascular risk, not having diseases of atherosclerotic genesis and requiring lipid-lowering drugs. Stage 2: a prospective observation of patients receiving primary medical prophylaxis of CVD with atorvastatin.

Conditions

• Lipid Metabolism Disorders

Interventions

Type	Name	Description
DRUG	atorvastatin	Profound patients' consultations (different from standard practice) on the importance of primary prevention of cardiovascular diseases, including preventive administration of statins. Subjects in profound consultation group will receive regular reminders (2 times a month) via SMS and phone calls to check following the doctor's recommendations and remind about follow-up visit to study centre.

Timeline

• Start date: 2018-06-21
• Primary completion: 2020-10-15
• Completion: 2020-10-15
• First posted: 2021-04-28
• Last updated: 2021-05-05

Locations

1 site across 1 country: Russia

Regulatory

• FDA-regulated drug study